StockNews.com started coverage on shares of Avinger (NASDAQ:AVGR – Free Report) in a research report report published on Sunday morning. The brokerage issued a hold rating on the medical device company’s stock.
Avinger Price Performance
AVGR stock opened at $1.04 on Friday. Avinger has a 1 year low of $0.90 and a 1 year high of $14.00. The firm has a market capitalization of $1.77 million, a PE ratio of -0.06 and a beta of 1.17. The business has a 50 day simple moving average of $1.31 and a 200-day simple moving average of $2.35.
Avinger (NASDAQ:AVGR – Get Free Report) last released its quarterly earnings data on Thursday, August 8th. The medical device company reported ($2.82) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.43) by ($2.39). The business had revenue of $1.85 million during the quarter, compared to the consensus estimate of $2.55 million. On average, equities research analysts expect that Avinger will post -4.69 EPS for the current year.
Institutional Investors Weigh In On Avinger
About Avinger
Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.
Featured Stories
- Five stocks we like better than Avinger
- Best Stocks Under $5.00
- Galmed Pharmaceuticals Surges 400%: What’s Behind the Explosion?
- Upcoming IPO Stock Lockup Period, Explained
- Gold Hits New All-Time Highs: 3 Stocks to Ride the Surge
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Intel: Why It’s Time to Reconsider This Beaten-Down Chipmaker
Receive News & Ratings for Avinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avinger and related companies with MarketBeat.com's FREE daily email newsletter.